Home / Stocks / ALDX

ALDX insider trading

Aldeyra Therapeutics, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
5
Bought · 24 mo
$546k
Buys · last 90 days
1 · $418k
Most recent buy
2026-06-05

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-06-05Brady Todd C
President and CEO
Bought250,000$1.67$418k
2026-03-20DOUGLAS RICHARD
Director
Bought70,000$1.40$98k
2026-03-19Alfieri Michael
Principal Financial Officer
Bought5,000$1.42$7k
2025-08-15Alfieri Michael
Principal Financial Officer
Bought2,500$5.30$13k
2025-04-07EDELMAN JOSEPH
10% owner
Sold3,400,000$1.42$4.8M
2024-10-21Miller-Rich Nancy
Director
Bought922$11.33$10k

Most active insider buyers

InsiderRoleBuysTotal bought
Brady Todd CPresident and CEO1$418k
DOUGLAS RICHARDDirector1$98k
Alfieri MichaelPrincipal Financial Officer2$20k
Miller-Rich NancyDirector1$10k

See ALDX on the chart

Every insider buy and sell for ALDX plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.